Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Byoung-Gie Kim"'
Autor:
Chel Hun Choi, Ji-Yoon Ryu, Young-Jae Cho, Hye-Kyung Jeon, Jung-Joo Choi, Kris Ylaya, Yoo-Young Lee, Tae-Joong Kim, Joon-Yong Chung, Stephen M. Hewitt, Byoung-Gie Kim, Duk-Soo Bae, Jeong-Won Lee
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-10 (2017)
Abstract We assessed the anti-proliferative activity of itraconazole using an EOC cell line (SKOV3ip1) and endothelial cell lines (HUVEC & SVEC4-10). We also examined angiogenesis (VEGFR2, p-ERK, p-PLCr1/2), hedgehog (Gli1, Ptch1, SMO), and mTOR (pS6
Externí odkaz:
https://doaj.org/article/e5ea0a7065c94edd9f99bdda3322c4ca
Autor:
Tae-Hyun Kim, E Sun Paik, Jung Joo Choi, Jason K. Sa, Young Jae Cho, Ji-Yoon Ryu, Yoo-Young Lee, Woo Young Kim, Jin Ku Lee, Hyung Jun Ahn, Byoung-Gie Kim, Chel Hun Choi, Hee Dong Han, Jeong-Won Lee, Duk-Soo Bae, Tae-Joong Kim
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-9 (2020)
Scientific Reports
Scientific Reports
Axitinib, small molecule tyrosine kinase inhibitor, demonstrates anti-cancer activity for various solid tumors. We investigated anti-cancer effect of axitinib in epithelial ovarian cancer (EOC). We treated EOC cells (A2780, HeyA8, RMG1, and HeyA8-MDR
Autor:
Won Soon Park, Hye-Kyung Jeon, Young Jae Cho, Changhoon Choi, Chel Hun Choi, Jae Ryoung Hwang, Byoung-Gie Kim, Jung-Joo Choi, Duk-Soo Bae, Ji-Yoon Ryu, Tae-Joong Kim, Jeong-Won Lee, Yoo-Young Lee, Sung-Won Shin
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-11 (2019)
Scientific Reports
Scientific Reports
Although the concurrent use of a chemotherapeutic agent and radiotherapy improves survival in patients with locally advanced or recurrent cervical cancer, severe side effects related to chemotherapy are frequent and may result in a low quality of lif
Autor:
Joon-Yong Chung, Kris Ylaya, Ji-Yoon Ryu, Jung-Joo Choi, Yoo-Young Lee, Stephen M. Hewitt, Byoung-Gie Kim, Jeong-Won Lee, Chel Hun Choi, Hye-Kyung Jeon, Duk-Soo Bae, Tae-Joong Kim, Young Jae Cho
Publikováno v:
Scientific Reports
Scientific Reports, Vol 7, Iss 1, Pp 1-10 (2017)
Scientific Reports, Vol 7, Iss 1, Pp 1-10 (2017)
We assessed the anti-proliferative activity of itraconazole using an EOC cell line (SKOV3ip1) and endothelial cell lines (HUVEC & SVEC4-10). We also examined angiogenesis (VEGFR2, p-ERK, p-PLCr1/2), hedgehog (Gli1, Ptch1, SMO), and mTOR (pS6K1) signa
Autor:
Chel Hun Choi, Jung-Joo Choi, Jeong-Won Lee, Duk-Soo Bae, Ji-Yoon Ryu, William Chi Cho, Ji Soo Lee, Sang Yong Song, Young Jae Cho, Heejin Bang, Byoung-Gie Kim, Aera Yoon, Ha-Jeong Kim
Publikováno v:
Scientific Reports
SCIENTIFIC REPORTS(6)
SCIENTIFIC REPORTS(6)
In this study, we investigated the therapeutic effects of c-MET inhibition in ovarian clear cell carcinoma (OCCC). Expression levels of c-MET in the epithelial ovarian cancers (EOCs) and normal ovarian tissues were evaluated using real-time PCR. To t
Autor:
Yoo-Young Lee, Young-Jae Cho, Sung-won Shin, Changhoon Choi, Ji-Yoon Ryu, Hye-Kyung Jeon, Jung-Joo Choi, Jae Ryoung Hwang, Chel Hun Choi, Tae-Joong Kim, Byoung- Gie Kim, Duk-Soo Bae, Won Park, Jeong-Won Lee
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-11 (2019)
Abstract Although the concurrent use of a chemotherapeutic agent and radiotherapy improves survival in patients with locally advanced or recurrent cervical cancer, severe side effects related to chemotherapy are frequent and may result in a low quali
Externí odkaz:
https://doaj.org/article/37fc5faa39024327940cb72635355416